Physician profile
Darcy D Harper
NPI 1093199325
$537.94
in general payments reported to CMS, 2019-2025
18 companies · $64.16 in 2025
The $64.16 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.95 · 2023: $403 · 2024: $54.71 · 2025: $64.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $76.65 | 2023 | Azstarys |
| Pfizer INC. | $50.34 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $45.88 | 2021-2023 | Farxiga |
| Exact Sciences Corporation | $43.29 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $39.00 | 2023-2024 | Freestyle Libre 3, Proclaim |
| Idorsia Pharmaceuticals US INC | $37.70 | 2023 | Quviviq |
| Glaxosmithkline, LLC. | $32.02 | 2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.63 | 2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $24.60 | 2025 | Keytruda |
| Kyowa Kirin, INC. | $23.98 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.65 | 2023 | |
| Novo Nordisk INC | $18.45 | 2023 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $17.66 | 2024 | |
| Nevro Corp. | $17.56 | 2023 | Senza |
| Amgen INC. | $17.15 | 2023 | Otezla, Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $16.19 | 2023 | Nexletol |
| Abbvie INC. | $15.61 | 2023 | |
| Celgene Corporation | $15.58 | 2025 | Reblozyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darcy Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.